| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |